✦ LIBER ✦

A molecular model for the interaction between vorozole and other non-steroidal inhibitors and human cytochrome P450 19 (P450 Aromatase)

✍ Scribed by Koymans, Luc M.H.; Moereels, Henri; Bossche, Hugo Vanden

Book ID: 120360782
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 581 KB
Volume: 53
Category: Article
ISSN: 0960-0760
DOI: 10.1016/0960-0760(95)00033-V

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An evaluation of the potential for pharm

An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir

✍ Marcelo M. Gutierrez; Jeffrey Rosenberg; Wattanaporn Abramowitz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 539 KB

A Mechanism-Based Pharmacokinetic Model

A Mechanism-Based Pharmacokinetic Model for the Cytochrome P450 Drug–Drug Interaction between Cyclophosphamide and ThioTEPA and the Autoinduction of Cyclophosphamide

✍ Alwin D. R. Huitema; Ron A. A. Mathôt; Matthijs M. Tibben; Sjoerd Rodenhuis; Jos 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 159 KB

Modeling Chemical Interaction Profiles:

Modeling Chemical Interaction Profiles: I. Spectral Data-Activity Relationship and Structure-Activity Relationship Models for Inhibitors and Non-inhibitors of Cytochrome P450 CYP3A4 and CYP2D6 Isozymes

✍ McPhail, Brooks; Tie, Yunfeng; Hong, Huixiao; Pearce, Bruce A.; Schnackenberg, L 📂 Article 📅 2012 🏛 Molecular Diversity Preservation International 🌐 English ⚖ 251 KB

Studies on the Interactions between Drug

Studies on the Interactions between Drugs and Estrogen: Analytical Method for Prediction System of Gynecomastia Induced by Drugs on the Inhibitory Metabolism of Estradiol Using Escherichia coli Coexpressing Human CYP3A4 with Human NADPH-Cytochrome P450 Reductase

✍ Takashi Satoh; Ken-ichi Fujita; Haruka Munakata; Shinji Itoh; Katsunori Nakamura 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 94 KB

To establish a prediction system for drug-induced gynecomastia in clinical fields, a model reaction system was developed to explain numerically this side effect. The principle is based on the assumption that 50% inhibition concentration (IC 50 ) of drugs on the in vitro metabolism of estradiol (E2)